Guest authorship, mortality reporting, and integrity in rofecoxib studies.
Maisonneuve
Hervé
H
D001319:Authorship; D035843:Biomedical Research; D016265:Conflict of Interest; D052246:Cyclooxygenase 2 Inhibitors; D003627:Data Interpretation, Statistical; D030881:Disclosure; D004345:Drug Industry; D007783:Lactones; D011643:Publishing; D013450:Sulfones
D052246:Cyclooxygenase 2 Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib